Streptococcal Infections: Clinical Trials

7 trials for Streptococcal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Terminated 7

Follow Streptococcal Infections: new trials by email Literature Review of Streptococcal Infections trials Research Report on Streptococcal Infections

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Duration of ANtibiotic Therapy for CEllulitis
Flucloxacillin, Placebo (for flucloxacillin) - Cellulitis, Erysipelas
Phase 4TerminatedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1512014-08-262017-10-10
Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
Phenytoin, placebo - Seizures, Pneumococcal Meningitis
Phase 4TerminatedM. Carmen Cabellos Minguez262011-11-012023-03-02
Short Course of Amoxicillin for Erysipelas
Amoxicillin - Erysipelas
Phase 4TerminatedAssistance Publique - Hôpitaux de Paris102010-09-012014-02-07
Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis
Penicillin versus cefuroxim per os - Streptococcal Infections
Phase 4TerminatedUniversity Children's Hospital Basel1942005-10-012007-01-17
Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
levofloxacin, ceftriaxone - Pneumonia, Pneumococcal
Phase 4TerminatedHospital Mutua de Terrassa452004-08-012007-02-01
Fucidin® Cream in the Treatment of Impetigo
Fucidin® cream - Impetigo
Phase 4TerminatedLEO Pharma582004-05-012025-03-06
Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants.
Pneumo 23 - Pneumococcal Infections
Phase 4TerminatedWyeth is now a wholly owned subsidiary of Pfizer512001-05-012006-08-24

Narrower conditions

Erysipelas (2)  ·  Cellulitis (1)  ·  Dermatitis (1)  ·  Impetigo (1)  ·  Meningitis, Pneumococcal (1)  ·  Pneumococcal Infections (1)  ·  Pneumonia, Pneumococcal (1)  ·  Seizures (1)

Broader conditions

Bacterial Infections (7)  ·  Bacterial Infections and Mycoses (7)  ·  Gram-Positive Bacterial Infections (7)  ·  Infections (7)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Skin Diseases, Bacterial (3)  ·  Skin Diseases, Infectious (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pneumococcal Infections (2)  ·  Central Nervous System Bacterial Infections (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Connective Tissue Diseases (1)

Interventions

Amoxicillin (1)  ·  Ceftriaxone (1)  ·  Floxacillin (1)  ·  Levofloxacin (1)  ·  Phenytoin (1)

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Hospital Mutua de Terrassa (1)  ·  LEO Pharma (1)  ·  M. Carmen Cabellos Minguez (1)  ·  University Children's Hospital Basel (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

France (2)  ·  Spain (2)  ·  Netherlands (1)  ·  Norway (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Jan M. Prins, MD, PhD (1)  ·  M. Carmen Cabellos, MD (1)  ·  Ulrich Heininger, MD (1)  ·  Urs B Schaad, MD (1)  ·  W. Joost Wiersinga, MD, PhD (1)

Results publications

PMID 24885384, PMID 30321312

NIH funding

2008 (1)